
ACTOv: A trial of adaptive chemotherapy in relapsed platinum-sensitive ovarian cancer
Researchers in this trial are looking to find out whether a new way of giving carboplatin chemotherapy (adaptive therapy "AT") is as safe as and more effective than the current standard way of giving carboplatin in women with advanced recurrent ovarian cancer. Recurrent ovarian cancer is usually treated with chemotherapy. The chemotherapy aims t…